C Chandra Bhagat Pharma Limited has announced a board meeting to discuss matters pertaining to corporate governance compliance.

The company qualifies for exemption under SEBI regulations due to its paid-up equity share capital being under ₹10 crore and net worth below ₹25 crore as of the previous financial year.

Consequently, it is not required to submit a Corporate Governance Report for the quarter ended 31 March 2025. This exemption may have a neutral impact on the company's operational governance structure, potentially streamlining compliance efforts and enabling management to focus on growth opportunities.